Gary Fanger
Director Ejecutivo en Rise Therapeutics LLC .
Perfil
Gary R.
Fanger is the founder of Rise Therapeutics LLC, which was founded in 2014, where he holds the titles of President & Chief Executive Officer.
Currently, he is a Director at OncoImmune, Inc. Dr. Fanger's former positions include Chief Executive Officer at EpicentRx, Inc., Head-Business Development at Corixa Corp., and Chief Operating Officer & Senior Vice President at Amplimmune, Inc. Dr. Fanger's education history includes a doctorate from Dartmouth College, an undergraduate degree from Denison University, and an MBA from Seattle University.
Cargos activos de Gary Fanger
Empresas | Cargo | Inicio |
---|---|---|
Rise Therapeutics LLC
Rise Therapeutics LLC BiotechnologyHealth Technology Rise Therapeutics LLC develops immunological-based biologics using proprietary oral delivery platform. It offers drugs for the treatment of inflammation, autoimmunity, and cancer. The company was founded by Gary Fanger and Neil Fanger on September 4, 2014 and is headquartered in Rockville, MD. | Director Ejecutivo | 04/09/2014 |
OncoImmune, Inc.
OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Gary Fanger.
Empresas | Cargo | Fin |
---|---|---|
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD. | Director de Operaciones | - |
EpicentRx, Inc.
EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Director Ejecutivo | - |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - |
Formación de Gary Fanger.
Dartmouth College | Doctorate Degree |
Denison University | Undergraduate Degree |
Seattle University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD. | Health Technology |
EpicentRx, Inc.
EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Health Technology |
OncoImmune, Inc.
OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Health Technology |
Rise Therapeutics LLC
Rise Therapeutics LLC BiotechnologyHealth Technology Rise Therapeutics LLC develops immunological-based biologics using proprietary oral delivery platform. It offers drugs for the treatment of inflammation, autoimmunity, and cancer. The company was founded by Gary Fanger and Neil Fanger on September 4, 2014 and is headquartered in Rockville, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Gary Fanger